Context-dependent effects of the CB1 receptor antagonist rimonabant on morphine-induced behavioral sensitization in female mice

Introduction: The endocannabinoid system has been implicated in the neurobiology of opioid use disorder. While the CB1 receptor antagonist rimonabant has been shown to block some of the behavioral effects of opioids, studies suggest that the treatment environment (i.e., receiving treatment in the dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Marinho, Eduardo A. V., Oliveira-Lima, Alexandre Justo, Reis, Henrique S., Santos-Baldaia, Renan, Wuo-Silva, Raphael, Hollais, Andre W., Yokoyama, Thais S., Frussa-Filho, Roberto, Berro, Lais F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939462/
https://www.ncbi.nlm.nih.gov/pubmed/36814501
http://dx.doi.org/10.3389/fphar.2023.1100527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939462/
https://www.ncbi.nlm.nih.gov/pubmed/36814501
http://dx.doi.org/10.3389/fphar.2023.1100527

Ejemplares similares